A Good Investment In HealthCare

A Good Investment In HealthCare

Forbes contributors Paul Howard and Yevgeniy Feyman take on the Cures Act, supported by Marsha Blackburn (TN-7), Cathy McMorris Rogers (WA-5), and Michael Burgess (TX-26), resulting in surprising support for the bill. According their recently authored Forbes article, “the Cures Act authorizes an additional $10 billion for the NIH over 5 years to help develop the NIH’s capacity to help the FDA in this mission.” While some conservatives might initially balk at these numbers, Howard and Feyman quickly remind readers that the “CBO has scored the bill as a net deficit reduction.” The concluded summation is simple: federal dollars for medical innovation with a net deficit deduction is a win-win for all.

Click here to read the full Forbes article.

 

No comments yet.

Leave a Reply